Research Frontiers (REFR)
(Delayed Data from NSDQ)
$2.09 USD
+0.02 (0.97%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $2.09 0.00 (0.00%) 5:18 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Research Frontiers Incorporated falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1 | 1 | 1 | 1 | 2 |
Cost Of Goods | 2 | 3 | 3 | 3 | 4 |
Gross Profit | -1 | -2 | -1 | -2 | -2 |
Selling & Adminstrative & Depr. & Amort Expenses | 1 | 1 | 1 | 1 | 1 |
Income After Depreciation & Amortization | -2 | -3 | -2 | -3 | -3 |
Non-Operating Income | 0 | 0 | 0 | 0 | -1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -2 | -3 | -2 | -2 | -4 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -2 | -3 | -2 | -2 | -4 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -2 | -3 | -2 | -2 | -4 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -2 | -2 | -2 | -3 | -3 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -2 | -3 | -2 | -3 | -3 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 33.45 | 32.07 | 31.65 | 31.49 | 30.01 |
Diluted EPS Before Non-Recurring Items | -0.06 | -0.08 | -0.06 | -0.07 | -0.07 |
Diluted Net EPS (GAAP) | -0.06 | -0.08 | -0.06 | -0.07 | -0.13 |
Fiscal Year end for Research Frontiers Incorporated falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.49 | 0.31 | 0.31 | 0.16 | 0.19 |
Cost Of Goods | 0.48 | 0.63 | 0.66 | 0.54 | 0.56 |
Gross Profit | 0.01 | -0.32 | -0.35 | -0.38 | -0.38 |
SG&A, R&D, and Dept/Amort Expenses | 0.13 | 0.15 | 0.15 | 0.14 | 0.15 |
Income After SG&A, R&D, and Dept/Amort Expenses | -0.12 | -0.47 | -0.50 | -0.52 | -0.53 |
Non-Operating Income | 0.02 | 0.03 | 0.03 | 0.04 | 0.03 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -0.09 | -0.44 | -0.48 | -0.47 | -0.49 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -0.09 | -0.44 | -0.48 | -0.47 | -0.49 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -0.09 | -0.44 | -0.48 | -0.47 | -0.49 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 33.52 | 33.51 | 33.45 | 33.51 | 33.51 |
Diluted EPS Before Non-Recurring Items | 0.00 | -0.01 | -0.02 | -0.01 | -0.01 |
Diluted Net EPS (GAAP) | 0.00 | -0.01 | -0.03 | -0.01 | -0.01 |